Emergent BioSolutions Inc. (EBS) › Total LiabilitiesEmergent BioSolutions Inc. (EBS) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $126.76M2011: $130.14M2012: $122.10M2013: $137.47M2014: $385.49M2015: $377.47M2016: $373.91M2017: $157.90M2018: $1.22B2019: $1.24B2020: $1.44B2021: $1.35B2022: $1.78B2023: $1.17B2024: $906.90M2025: $796.00M$796.00M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$796.00M-12.2%2024$906.90M-22.7%2023$1.17B-34.0%2022$1.78B+32.1%2021$1.35B-6.3%2020$1.44B+15.9%2019$1.24B+1.7%2018$1.22B+671.7%2017$157.90M-57.8%2016$373.91M-0.9%2015$377.47M-2.1%2014$385.49M+180.4%2013$137.47M+12.6%2012$122.10M-6.2%2011$130.14M+2.7%2010$126.76M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share